Empfehlung
27,4
Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
67.8
18 neu, 28 erhöht, 10,0M $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | GALECTIN THERAPEUTICS INC |
|---|---|
| Ticker | GALT |
| CIK | 0001133416 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | 363225129 |
|---|---|
| ISIN | US3632251290 |
| Typ | Common Stock |
| Titel | GALECTIN THERAPEU 26 WTS |
Status
| Zuletzt geprüft | 2026-03-20 22:38:03.053284 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2024-12-31 | 10-K | -47,047,000 | -0.76 | 17,495,000 | -104,793,000 |
Fondsaktivität (letzte 3 Quartale)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 2,288,848 | 2,247,967 | 40,881 | 9,521,608 | Aufgestockt | +1,8% | |
| OSAIC HOLDINGS, INC. | 1,090,590 | 1,224,724 | -134,134 | 4,536,850 | Reduziert | -11,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 881,619 | 567,678 | 313,941 | 3,667,535 | Aufgestockt | +55,3% | |
| BlackRock, Inc. | 796,558 | 797,669 | -1,111 | 3,313,681 | Reduziert | -0,1% | |
| GROUP ONE TRADING LLC | 649,100 | 281,010 | 368,090 | 2,700,256 | Aufgestockt | +131,0% | |
| MARSHALL WACE, LLP | 602,134 | 554,261 | 47,873 | 2,504,877 | Aufgestockt | +8,6% | |
| Wealthspire Advisors, LLC | 601,973 | 479,518 | 122,455 | 2,504,208 | Aufgestockt | +25,5% | |
| GEODE CAPITAL MANAGEMENT, LLC | 598,074 | 633,067 | -34,993 | 2,489,234 | Reduziert | -5,5% | |
| JANE STREET GROUP, LLC | 379,639 | 14,676 | 364,963 | 1,579,299 | Aufgestockt | +2486,8% | |
| COMMONWEALTH EQUITY SERVICES, LLC | 334,096 | 294,901 | 39,195 | 1,389,840 | Aufgestockt | +13,3% | |
| LPL Financial LLC | 325,256 | 360,268 | -35,012 | 1,353,065 | Reduziert | -9,7% | |
| GOLDMAN SACHS GROUP INC | 307,229 | 22,014 | 285,215 | 1,278,073 | Aufgestockt | +1295,6% | |
| MORGAN STANLEY | 279,288 | 228,335 | 50,953 | 1,161,837 | Aufgestockt | +22,3% | |
| Geneos Wealth Management Inc. | 243,327 | 360,175 | -116,848 | 1,012,240 | Reduziert | -32,4% | |
| STATE STREET CORP | 242,232 | 230,340 | 11,892 | 1,007,685 | Aufgestockt | +5,2% | |
| MILLENNIUM MANAGEMENT LLC | 235,508 | 110,422 | 125,086 | 979,713 | Aufgestockt | +113,3% | |
| Vivaldi Capital Management LP | 204,070 | 255,752 | -51,682 | 848,931 | Reduziert | -20,2% | |
| RETIREMENT GUYS FORMULA LLC | 184,562 | 165,993 | 18,569 | 767,778 | Aufgestockt | +11,2% | |
| Sovran Advisors, LLC | 225,874 | 157,405 | 68,469 | 711,503 | Aufgestockt | +43,5% | |
| 683 Capital Management, LLC | 162,484 | 0 | 162,484 | 675,933 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 142,220 | 0 | 142,220 | 591,635 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 130,448 | 121,065 | 9,383 | 542,664 | Aufgestockt | +7,8% | |
| SIMPLEX TRADING, LLC | 125,979 | 136,640 | -10,661 | 524,072 | Reduziert | -7,8% | |
| BARCLAYS PLC | 106,401 | 28,587 | 77,814 | 442,628 | Aufgestockt | +272,2% | |
| Fortis Capital Advisors, LLC | 106,139 | 0 | 106,139 | 441,538 | Neu | +100,0% | |
| Belpointe Asset Management LLC | 106,139 | 0 | 106,139 | 441,538 | Neu | +100,0% | |
| HighTower Advisors, LLC | 88,375 | 0 | 88,375 | 374,268 | Neu | +100,0% | |
| ExodusPoint Capital Management, LP | 82,478 | 0 | 82,478 | 343,108 | Neu | +100,0% | |
| Hudson Bay Capital Management LP | 78,145 | 14,826 | 63,319 | 325,083 | Aufgestockt | +427,1% | |
| Qube Research & Technologies Ltd | 74,643 | 60,867 | 13,776 | 310,515 | Aufgestockt | +22,6% | |
| Soltis Investment Advisors LLC | 140,750 | 0 | 140,750 | 296,983 | Neu | +100,0% | |
| TRUIST FINANCIAL CORP | 68,000 | 68,000 | 0 | 282,880 | Unverändert | 0,0% | |
| Ancora Advisors LLC | 52,380 | 13,000 | 39,380 | 221,829 | Aufgestockt | +302,9% | |
| XTX Topco Ltd | 51,936 | 42,805 | 9,131 | 216,054 | Aufgestockt | +21,3% | |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 51,484 | 53,742 | -2,258 | 214,173 | Reduziert | -4,2% | |
| UBS Group AG | 39,104 | 31,514 | 7,590 | 162,673 | Aufgestockt | +24,1% | |
| Solutions 4 Wealth, Ltd | 25,377 | 25,377 | 0 | 105,568 | Unverändert | 0,0% | |
| BANK OF AMERICA CORP /DE/ | 25,063 | 25,327 | -264 | 104,262 | Reduziert | -1,0% | |
| Stratos Wealth Partners, LTD. | 19,088 | 30,050 | -10,962 | 79,406 | Reduziert | -36,5% | |
| MANGROVE PARTNERS IM, LLC | 18,783 | 0 | 18,783 | 78,137 | Neu | +100,0% | |
| WOLVERINE TRADING, LLC | 18,000 | 11,100 | 6,900 | 75,960 | Aufgestockt | +62,2% | |
| Squarepoint Ops LLC | 16,462 | 0 | 16,462 | 68,482 | Neu | +100,0% | |
| Jefferies Financial Group Inc. | 16,435 | 17,300 | -865 | 68,370 | Reduziert | -5,0% | |
| Cetera Investment Advisers | 14,220 | 0 | 14,220 | 59,155 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 13,717 | 10,550 | 3,167 | 57,062 | Aufgestockt | +30,0% | |
| SIG BROKERAGE, LP | 13,596 | 15,717 | -2,121 | 56,559 | Reduziert | -13,5% | |
| BNP PARIBAS FINANCIAL MARKETS | 13,518 | 137 | 13,381 | 56,235 | Aufgestockt | +9767,2% | |
| Argyle Capital Partners, LLC | 13,375 | 13,375 | 0 | 55,640 | Unverändert | 0,0% | |
| FMR LLC | 12,807 | 12,707 | 100 | 53,278 | Aufgestockt | +0,8% | |
| Focus Partners Wealth | 12,596 | 12,262 | 334 | 52,399 | Aufgestockt | +2,7% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | ELDRED KARY | Director | Open Market Purchase | 300 | 2.70 | 810.00 | +1,2% | |
| 2026-01-06 | LEWIS JOEL | Director, Officer, President and CEO | Open Market Sale | -37,698 | 3.58 | -134,853.29 | -200,7% | |
| 2026-01-06 | Jamil Khurram | Officer, Chief Medical Officer | Open Market Sale | -21,446 | 3.65 | -78,204.98 | -116,4% | |
| 2026-01-06 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -20,354 | 3.67 | -74,695.11 | -111,1% | |
| 2026-01-05 | LEWIS JOEL | Director, Officer, President and CEO | Open Market Sale | -27,731 | 3.91 | -108,342.24 | -161,2% | |
| 2026-01-05 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -25,732 | 3.90 | -100,298.19 | -149,2% | |
| 2026-01-05 | Jamil Khurram | Officer, Chief Medical Officer | Open Market Sale | -25,499 | 3.90 | -99,407.85 | -147,9% | |
| 2026-01-02 | LEWIS JOEL | Director, Officer, President and CEO | Open Market Sale | -18,571 | 4.20 | -77,938.77 | -116,0% | |
| 2026-01-02 | Jamil Khurram | Officer, Chief Medical Officer | Open Market Sale | -13,055 | 4.20 | -54,789.22 | -81,5% | |
| 2026-01-02 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -13,914 | 4.20 | -58,394.28 | -86,9% | |
| 2025-12-31 | Jamil Khurram | Officer, Chief Medical Officer | Open Market Sale | -8,125 | 4.07 | -33,089.06 | -49,2% | |
| 2025-12-23 | FREEMAN KEVIN D | Director | Open Market Purchase | 5,500 | 3.55 | 19,514.00 | +29,0% | |
| 2025-12-23 | FREEMAN KEVIN D | Director | Open Market Purchase | 5,500 | 3.55 | 19,514.00 | +29,0% | |
| 2025-12-23 | ELDRED KARY | Director | Open Market Purchase | 700 | 3.73 | 2,611.00 | +3,9% | |
| 2025-12-23 | FREEMAN KEVIN D | Director | Open Market Purchase | 5,500 | 3.55 | 19,514.00 | +29,0% | |
| 2025-12-23 | ELDRED KARY | Director | Open Market Purchase | 700 | 3.73 | 2,611.00 | +3,9% | |
| 2025-12-17 | LEWIS JOEL | Director, Officer, President and CEO | Open Market Sale | -7,829 | 7.06 | -55,241.42 | -82,2% | |
| 2025-12-17 | Jamil Khurram | Officer, Chief Medical Officer | Open Market Sale | -8,500 | 7.04 | -59,840.00 | -89,0% | |
| 2025-12-17 | Jamil Khurram | Officer, Chief Medical Officer | Open Market Sale | -6,463 | 7.04 | -45,499.52 | -67,7% | |
| 2025-12-17 | Jamil Khurram | Officer, Chief Medical Officer | Open Market Sale | -4,479 | 7.04 | -31,532.16 | -46,9% | |
| 2025-12-17 | Shlevin Harold H. | Director | Open Market Sale | -4,706 | 7.04 | -33,120.83 | -49,3% | |
| 2025-12-17 | Shlevin Harold H. | Director | Open Market Sale | -19,793 | 7.04 | -139,303.13 | -207,3% | |
| 2025-12-15 | Shlevin Harold H. | Director | Open Market Sale | -8,417 | 6.30 | -53,027.10 | -78,9% | |
| 2025-12-12 | Shlevin Harold H. | Director | Open Market Sale | -19,793 | 6.27 | -124,181.28 | -184,8% | |
| 2025-12-09 | Shlevin Harold H. | Director | Open Market Sale | -16,790 | 6.27 | -105,206.14 | -156,5% | |
| 2025-12-08 | Shlevin Harold H. | Director | Open Market Sale | -4,000 | 6.01 | -24,020.00 | -35,7% | |
| 2025-12-08 | Shlevin Harold H. | Director | Open Market Sale | -20,000 | 6.00 | -120,040.00 | -178,6% | |
| 2025-12-08 | Shlevin Harold H. | Director | Open Market Sale | -35,000 | 6.02 | -210,665.00 | -313,5% | |
| 2025-12-08 | Shlevin Harold H. | Director | Open Market Sale | -25,000 | 5.95 | -148,650.00 | -221,2% | |
| 2025-12-08 | Shlevin Harold H. | Director | Open Market Sale | -20,000 | 5.96 | -119,240.00 | -177,4% | |
| 2025-12-08 | Shlevin Harold H. | Director | Open Market Sale | -35,000 | 5.95 | -208,250.00 | -309,9% | |
| 2025-12-08 | Shlevin Harold H. | Director | Open Market Sale | -20,000 | 5.96 | -119,240.00 | -177,4% | |
| 2025-11-18 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -28,100 | 6.22 | -174,866.30 | -260,2% | |
| 2025-11-18 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -18,210 | 6.22 | -113,320.83 | -168,6% | |
| 2025-11-18 | LEWIS JOEL | Director, Officer, President and CEO | Open Market Sale | -6,783 | 6.15 | -41,722.91 | -62,1% | |
| 2025-11-17 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -9,586 | 6.03 | -57,819.88 | -86,0% | |
| 2025-11-17 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -2,323 | 6.03 | -14,011.64 | -20,8% | |
| 2025-11-17 | LEWIS JOEL | Director, Officer, President and CEO | Open Market Sale | -15,680 | 6.04 | -94,642.91 | -140,8% | |
| 2025-11-17 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -19,701 | 6.03 | -118,830.52 | -176,8% | |
| 2025-11-13 | Jamil Khurram | Officer, Chief Medical Officer | Open Market Sale | -16,250 | 5.47 | -88,887.50 | -132,3% | |
| 2025-11-13 | Jamil Khurram | Officer, Chief Medical Officer | Open Market Sale | -41,500 | 5.47 | -227,005.00 | -337,8% | |
| 2025-11-13 | Jamil Khurram | Officer, Chief Medical Officer | Open Market Sale | -21,867 | 5.47 | -119,612.49 | -178,0% | |
| 2025-11-10 | LEWIS JOEL | Director, Officer, President and CEO | Open Market Sale | -1,867 | 6.03 | -11,252.22 | -16,7% | |
| 2025-11-10 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -1,736 | 6.03 | -10,467.73 | -15,6% | |
| 2025-11-10 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -1,675 | 6.03 | -10,094.56 | -15,0% | |
| 2025-11-10 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -1,880 | 6.02 | -11,321.36 | -16,8% | |
| 2025-11-05 | LEWIS JOEL | Director, Officer, President and CEO | Open Market Sale | -200 | 6.00 | -1,200.00 | -1,8% | |
| 2025-11-05 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -200 | 6.00 | -1,200.00 | -1,8% | |
| 2025-11-04 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -8,914 | 6.07 | -54,107.98 | -80,5% | |
| 2025-11-04 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -10,741 | 6.07 | -65,197.87 | -97,0% | |
| 2025-11-04 | LEWIS JOEL | Director, Officer, President and CEO | Open Market Sale | -14,420 | 6.07 | -87,529.40 | -130,2% | |
| 2025-11-04 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -8,974 | 6.07 | -54,472.18 | -81,1% | |
| 2025-11-03 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -1,260 | 6.01 | -7,572.60 | -11,3% | |
| 2025-11-03 | LEWIS JOEL | Director, Officer, President and CEO | Open Market Sale | -1,300 | 6.01 | -7,813.00 | -11,6% | |
| 2025-11-03 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -1,250 | 6.01 | -7,512.50 | -11,2% | |
| 2025-11-03 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -1,300 | 6.01 | -7,813.00 | -11,6% | |
| 2025-09-12 | CALLICUTT JACK W | Officer, Chief Financial Officer | Open Market Sale | -8,706 | 6.44 | -56,053.58 | -83,4% | |
| 2025-09-12 | LEWIS JOEL | Director, Officer, President and CEO | Open Market Sale | -14,000 | 6.36 | -89,048.40 | -132,5% | |
| 2025-07-21 | ELDRED KARY | Director | Open Market Purchase | 1,000 | 2.93 | 2,925.00 | +4,4% | |
| 2025-07-17 | FREEMAN KEVIN D | Director | Open Market Purchase | 5,000 | 2.90 | 14,495.00 | +21,6% |
Top-Fondshalter (aktuelles Quartal)
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| VANGUARD GROUP INC | 2,288,848 | 9,521,608 | 18.99 |
| OSAIC HOLDINGS, INC. | 1,090,590 | 4,536,850 | 9.05 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 881,619 | 3,667,535 | 7.32 |
| BlackRock, Inc. | 796,558 | 3,313,681 | 6.61 |
| GROUP ONE TRADING LLC | 649,100 | 2,700,256 | 5.39 |
| MARSHALL WACE, LLP | 602,134 | 2,504,877 | 5.00 |
| Wealthspire Advisors, LLC | 601,973 | 2,504,208 | 5.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 598,074 | 2,489,234 | 4.97 |
| JANE STREET GROUP, LLC | 379,639 | 1,579,299 | 3.15 |
| COMMONWEALTH EQUITY SERVICES, LLC | 334,096 | 1,389,840 | 2.77 |
| LPL Financial LLC | 325,256 | 1,353,065 | 2.70 |
| GOLDMAN SACHS GROUP INC | 307,229 | 1,278,073 | 2.55 |
| MORGAN STANLEY | 279,288 | 1,161,837 | 2.32 |
| Geneos Wealth Management Inc. | 243,327 | 1,012,240 | 2.02 |
| STATE STREET CORP | 242,232 | 1,007,685 | 2.01 |
| MILLENNIUM MANAGEMENT LLC | 235,508 | 979,713 | 1.95 |
| Vivaldi Capital Management LP | 204,070 | 848,931 | 1.69 |
| RETIREMENT GUYS FORMULA LLC | 184,562 | 767,778 | 1.53 |
| Sovran Advisors, LLC | 225,874 | 711,503 | 1.42 |
| 683 Capital Management, LLC | 162,484 | 675,933 | 1.35 |